ArcticZymes Technologies ASA (LTS:0DRV) Cash per Share: kr5.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0DRV ArcticZymes Technologies ASA LTS:0DRV
72 GF Score
Price kr20.80
GF Value kr26.24
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Cash per Share?

ArcticZymes Technologies ASA LTS:0DRV 72 Cash per Share is kr5.27 as of Jun. 2026. GuruFocus rates LTS:0DRV with a GF Score™ of 72/100 and a GF Value™ of kr26.24 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). ArcticZymes Technologies ASA's Cash per Share for the quarter that ended in Jun. 2026 was kr5.27.

ArcticZymes Technologies ASA  (LTS:0DRV) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

ArcticZymes Technologies ASA Cash per Share Related Terms

ArcticZymes Technologies ASA Cash per Share Historical Data

* Premium members only.

The historical data trend for ArcticZymes Technologies ASA's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Cash per Share Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.95 3.49 3.51 3.31 3.64

ArcticZymes Technologies ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.83 5.06 3.64 5.17 5.27
LTS:0DRV
72GF Score
ArcticZymes Technologies ASA LTS:0DRV
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArcticZymes Technologies ASA Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

ArcticZymes Technologies ASA's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=185.977/51.1
=3.64

ArcticZymes Technologies ASA's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=269.011/51.1
=5.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of kr5.27 mean?
ArcticZymes Technologies ASA (LTS:0DRV) has a Cash per Share of kr5.27 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for ArcticZymes Technologies ASA and its competitors.
Is ArcticZymes Technologies ASA's Cash per Share too high?
ArcticZymes Technologies ASA's current Cash per Share is kr5.27. Overall, ArcticZymes Technologies ASA has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Cash per Share compare to VRTX and REGN?
ArcticZymes Technologies ASA's Cash per Share of kr5.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Biotechnology company?
A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for ArcticZymes Technologies ASA and its competitors. ArcticZymes Technologies ASA's current Cash per Share is kr5.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr26.24, compared to a current price of kr20.80 — trading 20.7% below its estimated fair value. The current Cash per Share is kr5.27. ArcticZymes Technologies ASA's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Cash per Share is kr5.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr20.80 is trading 20.7% below its estimated GF Value™ of kr26.24. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for LTS:0DRV:

  • Cash per Share: kr5.27
  • GF Value™: kr26.24 vs. price of kr20.80 (20.7% below fair value)
  • GF Score™: 72/100 with 1 warning sign

No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:SwedenAZT:Norway
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
72GF Score

Get the complete analysis for LTS:0DRV

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.80
Price
kr26.24
GF Value